When can I start GLP-1 treatment after I stop breastfeeding
Clinical Insight Unlike bronchodilators, PDE-4 inhibitors primarily target inflammation rather than airway smooth muscle, making them useful in reducing COPD exacerbations rather than providing immediate bronchodilation
As illustrated in the cartoon, GLP-1 binding sites are distributed across multiple brain regions, suggesting a direct role for GLP-1 in modulating addiction-related pathways and improving brain health
The following side effects have been reported in subjects taking 3mg liraglutide for weight loss [24]: Nausea (39.3%) Diarrhea (20.9%) Constipation (19.4%) Vomiting (15.7%) Headache (up to 13.6%) Increases in mean resting heart rate (over 10% ) Less common side effects that occur in less than 10% of patients are: Dyspepsia Abdominal pain Gastroesophageal reflux disease Eructation Flatulence Dry mouth Elevated pancreatic enzymes Constipation Gastritis Abdominal discomfort Hypoglycemia Dizziness Hypotension Injection site reactions (pain, bleeding, redness, swelling, or itching) Rare but serious side effects include pancreatitis, gallbladder disease, cholestasis, and allergic reactions